TIBCO Software Inc. (NASDAQ:TIBX) and issuer Balboa Merger Sub, Inc., controlled by affiliates of sponsor Vista Equity Partners on 17 November have announced that the Balboa intends to privately offer, subject to market and other conditions, USD950 million in aggregate principal amount of its senior notes due 2021. TIBCO Software Inc. (NASDAQ:TIBX) in last trading activity advanced 0.38% to close at $24.03. Company weekly performance is 1.39% while its quarterly performance stands at 15.75%. TIBCO Software Inc. (NASDAQ:TIBX) is -3.49% away from its 52 week high.
RXi Pharmaceuticals Corporation (NASDAQ:RXII) on 13 November reported Net loss for the three months ended September 30, 2014 was $2.2 million, including $0.5 million in non-cash share-based compensation expense, compared to a net loss of $2.1 million, including $0.4 million in non-cash share-based compensation expense, for the three months ended September 30, 2013. On last trading day RXi Pharmaceuticals Corporation (NASDAQ:RXII) advanced 14.89% to close at $2.16. Its volatility for the week is 6.44% while volatility for the month is 5.33%. RXi Pharmaceuticals Corporation (NASDAQ:RXII) monthly performance is 5.37%.
La-Z-Boy Incorporated (NYSE:LZB) declared a quarterly dividend on Tuesday, November 18th, AnalystRatings.NET reports. Stockholders of record on Friday, November 28th will be given a dividend of 0.08 per share on Wednesday, December 10th. This represents a $0.32 dividend on an annualized basis and a yield of 1.42%. On last trading day La-Z-Boy Incorporated (NYSE:LZB) fell -0.15% to close at $25.90. Its volatility for the week is 2.63% while volatility for the month is 2.56%. LZB’s sales growth for past 5 years was 2.00% and its EPS growth for past 5 years was 19.70%. La-Z-Boy Incorporated (NYSE:LZB) monthly performance is 14.40%.
Cigna Corp., (NYSE:CI) a health insurer, on 8 November has agreed in a settlement to reduce the cost of certain HIV drugs for patients in Florida under the state’s health care plan, reports The New York Times. Two advocacy groups, the National Health Law Program and the AIDS Institute, filed a lawsuit in May against four health insurance companies, including Cigna, claiming that the providers were discriminating against people with HIV and AIDS by making their medications unlawfully expensive. Cigna has agreed to a cap of $200 per month that patients would have to pay out-of-pocket for many commonly prescribed HIV drugs. Cigna Corp. (NYSE:CI) has 0.30% insider ownership while its institutional ownership stands at 90.00%. In last trading activity company’s stock closed at $102.01.
Span-America Medical Systems Inc. (NASDAQ:SPAN) Director Thomas D. Henrion unloaded 2,500 shares of the stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $19.34, for a total value of $48,350.00. Following the completion of the transaction, the director now directly owns 124,584 shares of the company’s stock, valued at approximately $2,409,455.On Wednesday shares of Span-America Medical Systems Inc. (NASDAQ:SPAN) closed at $19.20. Company’s EPS growth for next 5 years is recorded as 13.00%.